SCHEMBL5159679

SCHEMBL5159679

NC(=O)c1cccc(C(=O)O)c1S(N)(=O)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.50
G6PD P11413 1/20 0.46
CASP7 P55210 1/20 0.46
CASP6 P55212 1/20 0.46
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 2/20 0.45
HPGD P15428 2/20 0.45
HSD17B10 Q99714 2/20 0.45
MAPT P10636 1/20 0.45
TSHR P16473 1/20 0.45
PKM P14618 1/20 0.43
RAB9A P51151 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
F2 P00734 2/20 0.42
PRSS1 P07477 2/20 0.42
PRSS2 P07478 2/20 0.42
PRSS3 P35030 2/20 0.42
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
CA9 Q16790 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11371039 0.92 ALOX15 (0.57) ALOX15G6PDCASP7CASP6ALDH1A1
SCHEMBL23849491 0.92 KDM4E (0.52) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL7736367 0.85 ALOX15 (0.50) ALOX15G6PDCASP7CASP6ALDH1A1
SCHEMBL28446319 0.82 MAPT (0.49) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL28069384 0.81 MMP2 (0.55) ALOX15G6PDCASP7CASP6ALDH1A1
SCHEMBL27999104 0.81 ALOX15 (0.50) ALOX15G6PDCASP7CASP6ALDH1A1
SCHEMBL32662842 0.80 AKR1C3 (0.58) ALOX15KDM4EMAPTCA1CA2
SCHEMBL11024382 0.79 ALDH1A1 (0.53) ALOX15G6PDCASP7CASP6ALDH1A1
SCHEMBL3778822 0.79 ALOX15 (0.49) ALOX15G6PDCASP7CASP6ALDH1A1
SCHEMBL3860114 0.79 ALB (0.53) ALOX15G6PDCASP7CASP6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130731-B2 Sulfonylureas and related compounds and use of same THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2021-09-28 US disclosed
EP-1747229-A1 STEROID PRODRUGS WITH ANDROGENIC EFFECT Schering Aktiengesellschaft (DE) 2007-01-31 EP disclosed
WO-2005113575-A1 STEROID PRODRUGS WITH ANDROGENIC EFFECT SCHERING AKTIENGESELLSCHAFT (DE) 2005-12-01 WO disclosed
US-5108487-A Herbicidal sulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-04-28 US disclosed
US-4927453-A Herbicidal sulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-05-22 US disclosed
US-4806142-A Herbicidal pyrimidine sulfonylureas E. I. DUPONT DE NEMOURS AND COMPANY (US) 1989-02-21 US disclosed
US-4655823-A Herbicidal sulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1987-04-07 US disclosed
US-4629494-A Herbicidal sulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1986-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130731-B2 Sulfonylureas and related compounds and use of same NLRP3, PYCARD, IAPP ALOX15 2371/4885G6PD 2350/4885CASP7 261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.